The EMA has released a guidance document on the post-authorisation centralised procedure.
This guidance document addresses a number of questions which marketing authorisation holders (MAHs) may have on post-authorisation procedures. It provides an overview of the Agency’s position on issues, which are typically addressed in discussions or meetings with MAHs in the post-authorisation phase.
European Medicines Agency
Need help with generating your licences? Samarind RMS is here to provide solutions to your regulatory management problems, contact us for a demonstration from our highly capable and professional team.